Novel plasma biomarker of atenolol-induced hyperglycemia identified through a metabolomics-genomics integrative approach

INTRODUCTION: While atenolol is an effective antihypertensive agent, its use is also associated with adverse events including hyperglycemia and incident diabetes that may offset the benefits of blood pressure lowering. By combining metabolomic and genomic data acquired from hypertensive individuals...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Metabolomics
Hlavní autoři: de Oliveira, Felipe A., Shahin, Mohamed H., Gong, Yan, McDonough, Caitrin W., Beitelshees, Amber L., Gums, John G., Chapman, Arlene B., Boerwinkle, Eric, Turner, Stephen T., Frye, Reginald F., Fiehn, Oliver, Kaddurah-Daouk, Rima, Johnson, Julie A., Cooper-DeHoff, Rhonda M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5310671/
https://ncbi.nlm.nih.gov/pubmed/28217400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11306-016-1076-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky